drugset / Trial / NCT06962462
Daily Tadalafil in Diabetic ED Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.
Timeline
- Start
- 2025-05-05
- Primary completion
- 2025-08-05
- Completion
- 2025-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 5 mg | Oral |